HIT Consultant July 31, 2024
Gav Martell, VP of Business Development & Co-founder at Yonalink

The Need to Address Accessibility Gaps

Clinical trials are a driving force of medical innovation. However, they are predominantly conducted in large urban hospitals that have larger staff and more resources, which puts trial participation out of reach for the majority of Americans who live outside of major city centers. Despite having as much interest as city-dwellers, these individuals often find participation in clinical trials nearly impossible due to daunting travel, logistical and financial challenges. Alarmingly, three out of four cancer patients eager to participate in clinical trials are thwarted by these barriers.

This lack of accessibility not only exacerbates existing healthcare disparities but also prevents underserved communities from accessing potentially life-saving treatments. The inadvertent exclusion of communities that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Equity/SDOH, Healthcare System, Patient / Consumer, Trends
Medtronic, Tempus testing AI to find potential TAVR patients
Legal and ethical challenges in AI-driven clinical trials
Biohaven muscle drug misses goal of SMA study, but advances in obesity
Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose
Will Walgreens’ store closures disrupt its clinical trial aims?

Share This Article